Characterising Alzheimer's disease through integrative NMR- and LC-MS-based metabolomics-Reference-Cited by-同舟云学术

Characterising Alzheimer's disease through integrative NMR- and LC-MS-based metabolomics

Published:2021-12 Issue: Volume:12 Page:100125
ISSN:2589-9368
Container-title:Metabolism Open
language:en
Short-container-title:Metabolism Open

Author:

Nielsen Jonas Ellegaard^ORCID,Maltesen Raluca Georgiana^ORCID,Havelund Jesper F.,Færgeman Nils J.,Gotfredsen Charlotte Held^ORCID,Vestergård Karsten,Kristensen Søren Risom,Pedersen Shona

Publisher

Elsevier BV

Subject

General Medicine

Reference60 articles.

1. Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions;Abeysinghe;Life Sci,2020

2. Alzheimer's disease beyond amyloid: can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?;Mullane;Biochem Pharmacol,2020

3. A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease;Panza;Nat Rev Neurol,2019

4. The causation of disease - the practical and ethical consequences of competing explanations;Räisänen;Med Health Care Philos,2006

5. Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids;Korecka;J Neurochem,2021

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical metabolomics: Useful insights, perspectives and challenges;Metabolism Open;2024-06

2. Extracellular Vesicles for Alzheimer’s Disease and Dementia Diagnosis;2024-04-24

3. Uric acid in health and disease: From physiological functions to pathogenic mechanisms;Pharmacology & Therapeutics;2024-04

4. Oral Microbiome Stamp in Alzheimer’s Disease;Pathogens;2024-02-23

5. Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients?;Environmental Science & Technology;2024-02-19